2-(吡啶-4-基)乙腈 | 13121-99-8

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-(吡啶-4-基)乙腈
• 中文别名: 4-吡啶乙腈；吡啶-4-乙腈
• 英文名称: pyridin-4-ylacetonitrile
• 英文别名: 4-pyridineacetonitrile；4-pyridylacetonitrile；2-(pyridin-4-yl)acetonitrile；4-pyridinylacetonitrile；2-pyridin-4-ylacetonitrile
• CAS: 13121-99-8
• 化学式: C₇H₆N₂
• mdl: MFCD03412601
• 分子量: 118.138
• InChiKey: BMVSAKPRNWZCPG-UHFFFAOYSA-N

物化性质

• 熔点：
  52-53 °C(Solv: ligroine (8032-32-4))
• 沸点：
  89-91 °C(Press: 0.1 Torr)
• 密度：
  1.085±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  36.7
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  6.1
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H312,H315,H319,H332,H335
• 储存条件：
  室温且干燥环境中存储。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Pyridin-4-yl-acetonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Pyridin-4-yl-acetonitrile
CAS number: 13121-99-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6N2
Molecular weight: 118.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN3439 Class: 6.1 Packing group: III
Proper shipping name: NITRILES, TOXIC, SOLID, N.O.S. (Pyridin-4-yl-acetonitrile)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(吡啶-4-基)乙腈 在 双氧水 、 sodium hydride 作用下， 以 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成 异烟酸
  参考文献：
  名称：

  作为潜在抗疟药的6-乙基-5-（4-吡啶基）-2,4-嘧啶二胺的合成研究†

  摘要：

  描述了嘧啶胺的吡啶类似物6-乙基-5-（4-吡啶基）-2,4-嘧啶二胺（2）的合成。将4-吡啶乙腈（3）与丙酸甲酯缩合，得到α-（1-氧丙基）-4-吡啶乙腈（4）。用原丙酸三乙酯处理主要得到不希望的N-烷基化物质。然而，粗混合物与胍的反应以低产率得到2。该物质没有明显的抗疟活性。

  DOI：

  10.1002/jhet.5570210321
• 作为产物：
  描述：

  4-吡啶甲醇 在 氯化亚砜 作用下， 以 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 2.5h， 生成 2-(吡啶-4-基)乙腈
  参考文献：
  名称：

  四唑酰肼类化合物是JumonjiC域含组蛋白去甲基化酶KDM4A的选择性片段样抑制剂

  摘要：

  含有JumonjiC域的组蛋白去甲基化酶2A（JMJD2A，KDM4A）是基因表达的表观遗传调控中的关键角色。以前的出版物表明，升高和降低的酶水平均与某些类型的癌症有关，因此，KDM4A在肿瘤发生中的明确作用仍然难以捉摸。为了鉴定具有良好理化性质的新型分子起点来研究KDM4A的生理作用，我们通过使用两次独立的试验筛选了许多带有铁螯合部分的分子。通过这种方法，我们能够鉴定出2-（1 H-四唑-5-基）乙酰肼为新颖的类似片段的铅结构，相对分子质量低（M r = 142 Da），复杂度低，并且IC 5046.6μ值米在甲醛脱氢酶（FDH） -偶联测定法和2.4μ米在基于抗体的测定法。尽管它的体积很小，但是对于该化合物而言，可以证明它对另外两种脱甲基酶的相对选择性。这是四唑基团作为JMJD脱甲基酶中的战斗部的第一个例子。

  DOI：

  10.1002/cmdc.201500335

文献信息

• Synthesis of (E)-3-(2-carboxy-2-pyridyl-vinyl)-4,6-dichloro-1H-indole-2-carboxylic acids, glycine-site NMDA receptor antagonists, utilizing the Knoevenagel condensation reaction
  作者：Robert J Cregge、Robert A Farr、Dirk Friedrich、Jos Hulshof、David A Janowick、Scott Meikrantz、William A Metz

  DOI：10.1016/s0040-4039(00)02270-x

  日期：2001.2

  The Knoevenagel condensation of arylacetonitriles with ethyl 4,6-dichloro-3-formyl-1H-indole-2-carboxylate (2), followed by hydrolysis, provides a convenient entry into a series of analogs of MDL 105,519, 1, a selective glycine site N-methyl-d-aspartate (NMDA) receptor antagonist. Surprisingly, the hydrolysis of the indole arylpropenenitriles terminates at the formation of the corresponding carboxamide

  arylacetonitriles的Knoevenagel缩合用乙酸乙酯4,6-二氯-3-甲酰基-1- ħ -吲哚-2-羧酸甲酯（2），接着进行水解，提供了方便的入口成一系列MDL 105519，类似物的1，选择性甘氨酸位点N-甲基-d-天冬氨酸（NMDA）受体拮抗剂。令人惊讶地，吲哚芳基丙烯腈的水解终止于相应羧酰胺的形成，并且没有进一步进行为所需的二羧酸。然而，当芳基取代基是吡啶时，水解通过该系列独特的氮杂环庚烷吲哚进行，其在进一步水解时平稳地转化为所需的二羧酸类似物。
• Lithium Naphthalenide-Induced Reductive Alkylation and Addition of Aryl- and Heteroaryl- Substituted Dialkylacetonitriles
  作者：Hsing-Jang Liu、Jia-Liang Zhu、Jing-Po Tsao、Ting-Yueh Tsai、I-Chia Chen、Sheng-Wei Tsao

  DOI：10.1055/s-0030-1258301

  日期：2010.12

  desired reductive alkylation of 2-thienyldialkylacetonitriles, a much lower temperature such as -100 ˚C was required. Also with these substrates, an interesting ring-opening/S-alkylation process was observed when the reductive alkylation were performed at -78 ˚C to give 1-alkylsulfanyl-1,3,4-trienes. A mechanistic discussion is given for this observation. reductive alkylation - reductive addition - reductive

  研究了萘锂（LN）诱导的芳基，吡啶基和2-噻吩基取代的二烷基乙腈的还原烷基化/加成反应。在-40°C的THF中用LN处理后，芳基和吡啶基前体均可顺利进行还原性脱氰作用，并且原位生成的碳负离子很容易被卤代烷，酮，醛或什至氧气捕获，从而提供了宽范围带有新建立的季碳的官能化芳族衍生物的制备 为了实现所需的2-噻吩基二烷基乙腈的还原性烷基化反应，需要低得多的温度，例如-100°C。同样在这些底物上，当在-78°C下进行还原烷基化反应时，观察到有趣的开环/ S-烷基化过程，得到1-烷基硫烷基-1,3,4-三烯。 还原烷基化-还原加成-还原脱氰-腈-萘锂-芳基衍生物-杂芳基衍生物-取代的1,3,4-三烯
• Structural Factors Affecting the Basicity of ?-Pyridylalkanols, ?-Pyridylalkanamides and ?-Pyridylalkylamines
  作者：Joachim M. Mayer、Bernard Testa

  DOI：10.1002/hlca.19820650621

  日期：1982.9.22

  The present paper describes the preparation by conventional methods (when not available commercially) and the pKa-determination of the α-, β- and γ-isomers of pyridylethanamide, 3-pyridylpropanamide. 4-pyridylbutanamide, 5-pyridyl-pentanamide, pyridylmethanol, 2-pyridylethanol, 3-pyridylpropanol, 4-pyridyl-butanol, 5-pyridylpentanol, pyridylmethylamine, 2-pyridylethylamine, 3-pyridyl-propylamine, 4-pyridylbutylamine

  本文件描述了通过常规方法制备（当不市售）和p ķ一个所述的α--determination，β-和pyridylethanamide的γ -异构体，3- pyridylpropanamide。4-吡啶基丁酰胺，5-吡啶基戊酰胺，吡啶甲醇，2-吡啶基乙醇，3-吡啶基丙醇，4-吡啶基丁醇，5-吡啶基戊醇，吡啶基甲胺，2-吡啶基乙胺，3-吡啶基-丙胺，4-吡啶基丁胺和5-吡啶基戊胺。尽管场效应解释了p K a随链长变化的许多变化，但在某些甲基和乙基同系物中，明显的感应效应是有效的。在P ķ一在属于α系列的一些较低的同系物中，分子内H键的递减影响也是明显的。
• Basic enemies of photochromism: irreversible transformation of fluorinated diarylethenes to polyenic enamines and enols
  作者：Dmytro Sysoiev、Thomas Huhn

  DOI：10.1039/d0pp00292e

  日期：2020.11

  Non-photochemical degradation of perfluorinated photochromic diarylethenes (DAE) under Knoevenagel, Sonogashira or Wittig conditions was discovered. This base promoted formation of strongly colored non-photochromic byproducts has an impact in the field of molecular electronics due to the basic conditions often employed during deacylation and desilylation of the protected thiol anchoring groups of functionalized DAE. The products were identified as seven-membered ring systems of the bicyclo[5.3.0]deca-1,7-diene type. Their formation was rationalized by a tentative two-step reaction mechanism.

  在Knoevenagel、Sonogashira或Wittig条件下，发现全氟化光致变色二芳基乙烯（DAE）的非光化学降解。这种碱促进的生成具有强烈颜色的非光致变色副产物对分子电子学领域产生了影响，因为在去酰化和脱硅烷化过程中，常常使用基本条件处理功能化DAE的保护硫醇锚定基团。产物被鉴定为双环[5.3.0]十碳-1,7-二烯型的七元环体系。它们的形成可通过一个暂定的两步反应机理解释。
• Substituted pyrrolidin-3-yl-alkyl-piperidines
  申请人：Merrell Pharmaceuticals Inc.

  公开号：US05635510A1

  公开（公告）日：1997-06-03

  The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.

  本发明涉及取代吡咯啉基-3-基-烷基-哌啶、其立体异构体和药学上可接受的盐以及其制备方法。本发明的化合物在药理活性方面具有用途，如快速激肽拮抗作用，特别是物质P和神经激肽A的拮抗作用等。具有快速激肽拮抗性质的化合物适用于与神经源性炎症和本文所述的其他疾病相关的情况。